Evidence map›Paper›PMID 41237153›Full record

ArticlePloS one2025

Prevalence of extended spectrum β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in raw bulk cow milk from dairy cooperatives, Northwest Amhara, Ethiopia.

Chalachew Genet, Wendemagegn Enbiale, Anna Rommerskirchen, Rajiha Abubeker, Wudu Tafere, Tsehaynesh Gebre-Eyesus, Michael Getie, Alem Tsega, Muluken Acham, Addisu Melese and 10 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Chalachew GenetHealth Biotechnology Division, Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0001-8631-5094
Wendemagegn EnbialeDepartment of Dermatovenereology, Bahir Dar University, Bahir Dar, Ethiopia.
Anna RommerskirchenInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University, Düsseldorf, Germany.
Rajiha AbubekerEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Wudu TafereAmhara Public Health Institute, Bahir Dar, Ethiopia.
Tsehaynesh Gebre-EyesusAmhara Public Health Institute, Bahir Dar, Ethiopia.
Michael GetieAmhara Public Health Institute, Bahir Dar, Ethiopia.
Alem TsegaAmhara Public Health Institute, Bahir Dar, Ethiopia.
Muluken AchamAmhara Public Health Institute, Bahir Dar, Ethiopia.
Addisu MeleseDepartment of Medical Microbiology, Bahir Dar University, Bahir Dar, Ethiopia.
Tewachew AwokeDepartment of Medical Microbiology, Bahir Dar University, Bahir Dar, Ethiopia.
Wondemagegn MuluDepartment of Medical Microbiology, Bahir Dar University, Bahir Dar, Ethiopia.
Degu AshagrieDiagnostic Medical Microbiology Unit, Felege-Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.
Tadele AmsaluDiagnostic Medical Microbiology Unit, Tibebe-Ghion Specialized Hospital, Bahir Dar, Ethiopia.
Achenef MotbainorSchool of Public Health, Bahir Dar University, Bahir Dar, Ethiopia.
Endalew GebeyehuDepartment of Pharmacy, Bahir Dar University, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0003-3330-4513
Mulugeta KibretDepartment of Biology, Bahir Dar University, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0003-3320-0802
Bayeh AberaDepartment of Medical Microbiology, Bahir Dar University, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0002-2559-6635
Endalkachew NibretHealth Biotechnology Division, Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia.
Abaineh MunsheaHealth Biotechnology Division, Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExtended spectrum β-lactamase (ESBL) and carbapenemase-producing Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) emanating from raw cow milk are among the leading contributors to the spread of antimicrobial resistance (AMR). Due to the misuse and overuse of antibiotics in dairy farms, cow's milk has become a reservoir of ESBL- and carbapenemase-producing E. coli and K. pneumoniae posing a growing public health threat, especially in areas where the consumption of raw milk is common. However, compared to the clinical sector, the prevalence of ESBL- and carbapenemase-producing E. coli and K. pneumoniae in the food sector is under-studied.

objectiveThis study aimed to determine the prevalence of ESBL and carbapenemase-producing E. coli and K. pneumoniae in raw bulk cow milk from Dairy Cooperatives in Northwest Amhara, Ethiopia.

methodsA cross-sectional study was conducted from January to April, 2025 among 257 dairy cooperative member farms. Sociodemographic and related data were collected using a structured questionnaire. Five milliliters of raw bulk cow milk were collected aseptically from each farm in four Dairy Cooperatives (DCs) (DC-A to D). 10 microliters of milk sample were directly inoculated into MacConkey agar. Escherichia coli and K. pneumoniae were identified using standard microbiological techniques. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method. ESBL and carbapenemase production were confirmed phenotypically via combination disk tests and modified carbapenem inactivation methods, respectively.

resultsThe prevalence of E. coli and/or K. pneumoniae in raw cow milk was 21% (95% CI, 16.5-26.4%), with respective individual prevalence of 8.2% and 14.8%. ESBL-producing E. coli and K. pneumoniae accounted for 23.8% and 15.8% of isolates, respectively, while 2.6% of isolates (only K. pneumoniae) were carbapenemase producers. Resistance to ampicillin and amoxicillin-clavulanic acid exceeded 70%. All E. coli and 94.7% of K. pneumoniae isolates remained susceptible to carbapenems. Nearly half of all isolates (45.8%) were multidrug resistant (MDR), and 51.9% of MDR isolates were co-resistant to at least six antibiotics. Having additional non-farming occupations (AOR: 4.17, 95% CI: 1.49-11.67), large herd size (AOR: 3.21, 95% CI: 1.26-8.18), having pet animals (AOR: 6.53, 95% CI: 1.39-30.7), and use of calabash milk pail (AOR: 7.37, 95% CI: 1.45-37.49) were significantly associated with milk culture positive result for E. coli and/or K. pneumoniae.

conclusionRaw milk in Northwest Amhara harbors ESBL and carbapenemase-producing E. coli and K. pneumoniae posing a substantial public health risk coupled with MDR and resistance to critically important antimicrobials. Strengthened AMR surveillance, improved farm hygiene, restricted antibiotic use, and public education on milk safety are urgently needed.

Indexed as

Bacterial Proteinsbeta-LactamasesEscherichia coliKlebsiella pneumoniaeMilkAnimalsAnti-Bacterial AgentsCattleCross-Sectional StudiesDairyingEthiopiaFemaleMicrobial Sensitivity TestsPrevalenceAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID41237153
PMCPMC12617854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.